Oncology News

In this video, Ronny Drapkin, MD, discusses challenges in diagnosing ovarian cancer.

Acupuncture significantly reduced hot flashes and improved quality of life in women receiving endocrine therapy for breast cancer in three parallel randomized trials, according to results published in Cancer.

The FDA approved the use of durvalumab in combination with carboplatin and paclitaxel followed by single-agent durvalumab for women with mismatch repair-deficient primary advanced or recurrent endometrial cancer.

Past-year Pap smear testing rates were lower in 2022 than in 2019, highlighting the need to increase screening access, especially in rural areas, to prevent cervical cancer, researchers reported in JAMA Network Open.

The FDA approved the use of pembrolizumab in combination with chemotherapy for adults with primary advanced or recurrent endometrial carcinoma.

Living in the most deprived neighborhoods was associated with increased breast cancer mortality among white, but not Black, women, according to a cohort study published in JAMA Network Open.

BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.

PHILADELPHIA — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, highlights the need for greater prevention of myocardial infarction and cardiovascular death in young women.

New evidence suggests that a novel, benign nail finding may facilitate the detection of BRCA1-associated protein tumor predisposition syndrome which leaves patients at risk for certain cancers, according to a study.

Endometriosis was significantly associated with higher risks for both ovarian and endometrial cancers, but was not significantly associated with cervical cancer risk, according to an analysis published in Current Oncology.